Accellacare of Duly Oak Lawn — Oak Lawn, Illinois

Accellacare of Duly Oak Lawn is a clinical research site located in Oak Lawn, Illinois, United States 60453.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Accellacare of Duly Oak Lawn has participated in 1 clinical trials.

Therapeutic areas: Diabetes Mellitus, Type 2.

Sponsors: Novo Nordisk A/S.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Oak Lawn

Browse all research sites in Illinois · View every site in Oak Lawn

• Advocate Christ Hospital and Medical Center
• Advocate Christ Medical Center-Hospital
• Advocate Chilldren's Hospital
• Adcovate Christ Hospital
• Advocate Hope Children's Hospital
• Advocate Childrens Hospital
• Advocate Children's Hospital
• Advocate Health and Hospital
• Advocate Christ Hospital
• Advocate Christ Hospital & Medical Center
• Christ Hospital
• Hope Children's Hospital

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Accellacare of Duly Oak Lawn?

Accellacare of Duly Oak Lawn has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Accellacare of Duly Oak Lawn conducted?

Accellacare of Duly Oak Lawn has 1 clinical trials on record. Their work covers Diabetes Mellitus, Type 2.

Is Accellacare of Duly Oak Lawn accredited by Crixeo Clinical Trials?

Accellacare of Duly Oak Lawn has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Accellacare of Duly Oak Lawn?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.